International Journal of General Medicine (Feb 2020)
Management Strategies of Melkersson-Rosenthal Syndrome: A Review
Abstract
Sumeet R Dhawan,1 Arushi G Saini,2 Pratibha D Singhi2,3 1Department of Pediatrics, Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, Ambala, 133207, India; 2Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India; 3Medanta, The Medicity, Gurgaon, Haryana, IndiaCorrespondence: Pratibha D Singhi Medanta, The Medicity, Gurgaon, Haryana, IndiaTel +91 8168186894Email [email protected]: Melkerrson-Rosenthal syndrome is a rare disorder of unknown aetiology and characterized by the triad of oro-facial edema, facial nerve palsy, and furrowing of the tongue. Two or more of the above are essential for making a clinical diagnosis. The mainstay of treatment is corticosteroids. Intralesional triamcinolone acetonide may be used for the treatment of oro-facial edema. Another treatment option for oro-facial edema includes intralesional betamethasone, along with oral doxycycline. The review discusses the management strategies in Melkersson-Rosenthal syndrome.Keywords: facial palsy, Bell’s palsy, facial edema, lip edema, orofacial granulomatosis, recurrent facial palsy, fissured tongue, lingua plicata
